Related Experiment Video
Updated: Jul 23, 2025

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
The winding journey of biotech capital raising: deciphering the jargon
Nicholas Frame1, Michael Casasanta1, Oded Ben-Joseph1
1Outcome Capital, LLC, 99 High Street Suite 2900, Boston, MA 02110, USA.
Abstract:
Ensuring biotech companies are sufficiently capitalized to propel innovation and development remains a central focus for management. In this article, we draw on our broad perspective interacting with venture capitalists to offer thoughts on investor feedback. Understanding venture capitalists' mindsets and investment theses will increase the probability of securing needed capital.
Related Concept Videos
Plant Breeding and Biotechnology
Recombinant DNA
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
RACE - Rapid Amplification of cDNA Ends
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

